 | • レポートコード：MRC2-11QY10916 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は心房細動（AF）診断のグローバル市場について調査・分析したレポートです。種類別（心電図（ECG）、心エコー図（エコー）、経食道心エコー検査（TEE）、胸部X線、血液検査、ストレス検査、電気的活動検査）市場規模、用途別（カーディオセンター、大病院、心臓専門医療企業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別心房細動（AF）診断の競争状況、市場シェア ・世界の心房細動（AF）診断市場：種類別市場規模 2015年-2020年（心電図（ECG）、心エコー図（エコー）、経食道心エコー検査（TEE）、胸部X線、血液検査、ストレス検査、電気的活動検査） ・世界の心房細動（AF）診断市場：種類別市場規模予測 2021年-2026年（心電図（ECG）、心エコー図（エコー）、経食道心エコー検査（TEE）、胸部X線、血液検査、ストレス検査、電気的活動検査） ・世界の心房細動（AF）診断市場：用途別市場規模 2015年-2020年（カーディオセンター、大病院、心臓専門医療企業） ・世界の心房細動（AF）診断市場：用途別市場規模予測 2021年-2026年（カーディオセンター、大病院、心臓専門医療企業） ・北米の心房細動（AF）診断市場分析：米国、カナダ ・ヨーロッパの心房細動（AF）診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの心房細動（AF）診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の心房細動（AF）診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの心房細動（AF）診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Becton、Dickinson & Company、Medtronic、Boston Scientific Corp、Sanofi-Aventis、Zimmer Holdings、Abbott、Baxter International、AtriCure ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain.
Factors such as aging of population and sedentary life style resulting in rapidly increasing prevalence of cardiac diseases worldwide are driving the growth of the global atrial fibrillation diagnostics market. On the other hand, high cost involved in diagnosis of atrial fibrillation on the grounds of high equipment costs and scarce availability of diagnostic facilities is restraining the growth of atrial fibrillation diagnostics market. As atrial fibrillation diagnostic tools are costly, reprocessed diagnostic catheters market shows growth potential.
Market Analysis and Insights: Global Atrial Fibrillation (AF) Diagnostics Market
The global Atrial Fibrillation (AF) Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Atrial Fibrillation (AF) Diagnostics Scope and Market Size
Atrial Fibrillation (AF) Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atrial Fibrillation (AF) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Becton
Dickinson & Company
Medtronic
Boston Scientific Corp
Sanofi-Aventis
Zimmer Holdings
Abbott
Baxter International
AtriCure
Market segment by Type, the product can be split into
Electrocardiogram (ECG)
Echocardiogram (echo)
Transesophageal Echocardiography (TEE)
Chest X-ray
Blood Tests
Stress Testing
Electrical Activity Testing
Market segment by Application, split into
Cardio Centers
Big Hospitals
Heart Specialty Care Enterprises
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Atrial Fibrillation (AF) Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Atrial Fibrillation (AF) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Electrocardiogram (ECG)
1.4.3 Echocardiogram (echo)
1.4.4 Transesophageal Echocardiography (TEE)
1.4.5 Chest X-ray
1.4.6 Blood Tests
1.4.7 Stress Testing
1.4.8 Electrical Activity Testing
1.5 Market by Application
1.5.1 Global Atrial Fibrillation (AF) Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Cardio Centers
1.5.3 Big Hospitals
1.5.4 Heart Specialty Care Enterprises
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Atrial Fibrillation (AF) Diagnostics Market Perspective (2015-2026)
2.2 Global Atrial Fibrillation (AF) Diagnostics Growth Trends by Regions
2.2.1 Atrial Fibrillation (AF) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Atrial Fibrillation (AF) Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Atrial Fibrillation (AF) Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Atrial Fibrillation (AF) Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Atrial Fibrillation (AF) Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Atrial Fibrillation (AF) Diagnostics Players by Market Size
3.1.1 Global Top Atrial Fibrillation (AF) Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Atrial Fibrillation (AF) Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Atrial Fibrillation (AF) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Atrial Fibrillation (AF) Diagnostics Market Concentration Ratio
3.2.1 Global Atrial Fibrillation (AF) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Atrial Fibrillation (AF) Diagnostics Revenue in 2019
3.3 Atrial Fibrillation (AF) Diagnostics Key Players Head office and Area Served
3.4 Key Players Atrial Fibrillation (AF) Diagnostics Product Solution and Service
3.5 Date of Enter into Atrial Fibrillation (AF) Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Atrial Fibrillation (AF) Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Atrial Fibrillation (AF) Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
5.2 Global Atrial Fibrillation (AF) Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
6.2 Atrial Fibrillation (AF) Diagnostics Key Players in North America (2019-2020)
6.3 North America Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
6.4 North America Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
7.2 Atrial Fibrillation (AF) Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
7.4 Europe Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
8.2 Atrial Fibrillation (AF) Diagnostics Key Players in China (2019-2020)
8.3 China Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
8.4 China Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
9.2 Atrial Fibrillation (AF) Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
9.4 Japan Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
10.2 Atrial Fibrillation (AF) Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
11.2 Atrial Fibrillation (AF) Diagnostics Key Players in India (2019-2020)
11.3 India Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
11.4 India Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Atrial Fibrillation (AF) Diagnostics Market Size (2015-2020)
12.2 Atrial Fibrillation (AF) Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Becton
13.1.1 Becton Company Details
13.1.2 Becton Business Overview
13.1.3 Becton Atrial Fibrillation (AF) Diagnostics Introduction
13.1.4 Becton Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020))
13.1.5 Becton Recent Development
13.2 Dickinson & Company
13.2.1 Dickinson & Company Company Details
13.2.2 Dickinson & Company Business Overview
13.2.3 Dickinson & Company Atrial Fibrillation (AF) Diagnostics Introduction
13.2.4 Dickinson & Company Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.2.5 Dickinson & Company Recent Development
13.3 Medtronic
13.3.1 Medtronic Company Details
13.3.2 Medtronic Business Overview
13.3.3 Medtronic Atrial Fibrillation (AF) Diagnostics Introduction
13.3.4 Medtronic Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.3.5 Medtronic Recent Development
13.4 Boston Scientific Corp
13.4.1 Boston Scientific Corp Company Details
13.4.2 Boston Scientific Corp Business Overview
13.4.3 Boston Scientific Corp Atrial Fibrillation (AF) Diagnostics Introduction
13.4.4 Boston Scientific Corp Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.4.5 Boston Scientific Corp Recent Development
13.5 Sanofi-Aventis
13.5.1 Sanofi-Aventis Company Details
13.5.2 Sanofi-Aventis Business Overview
13.5.3 Sanofi-Aventis Atrial Fibrillation (AF) Diagnostics Introduction
13.5.4 Sanofi-Aventis Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.5.5 Sanofi-Aventis Recent Development
13.6 Zimmer Holdings
13.6.1 Zimmer Holdings Company Details
13.6.2 Zimmer Holdings Business Overview
13.6.3 Zimmer Holdings Atrial Fibrillation (AF) Diagnostics Introduction
13.6.4 Zimmer Holdings Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.6.5 Zimmer Holdings Recent Development
13.7 Abbott
13.7.1 Abbott Company Details
13.7.2 Abbott Business Overview
13.7.3 Abbott Atrial Fibrillation (AF) Diagnostics Introduction
13.7.4 Abbott Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.7.5 Abbott Recent Development
13.8 Baxter International
13.8.1 Baxter International Company Details
13.8.2 Baxter International Business Overview
13.8.3 Baxter International Atrial Fibrillation (AF) Diagnostics Introduction
13.8.4 Baxter International Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.8.5 Baxter International Recent Development
13.9 AtriCure
13.9.1 AtriCure Company Details
13.9.2 AtriCure Business Overview
13.9.3 AtriCure Atrial Fibrillation (AF) Diagnostics Introduction
13.9.4 AtriCure Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020)
13.9.5 AtriCure Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Atrial Fibrillation (AF) Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Atrial Fibrillation (AF) Diagnostics Revenue
Table 3. Ranking of Global Top Atrial Fibrillation (AF) Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Atrial Fibrillation (AF) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Electrocardiogram (ECG)
Table 6. Key Players of Echocardiogram (echo)
Table 7. Key Players of Transesophageal Echocardiography (TEE)
Table 8. Key Players of Chest X-ray
Table 9. Key Players of Blood Tests
Table 10. Key Players of Stress Testing
Table 11. Key Players of Electrical Activity Testing
Table 12. Global Atrial Fibrillation (AF) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Atrial Fibrillation (AF) Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Atrial Fibrillation (AF) Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Atrial Fibrillation (AF) Diagnostics Market Share by Regions (2015-2020)
Table 16. Global Atrial Fibrillation (AF) Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Atrial Fibrillation (AF) Diagnostics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Atrial Fibrillation (AF) Diagnostics Market Growth Strategy
Table 22. Main Points Interviewed from Key Atrial Fibrillation (AF) Diagnostics Players
Table 23. Global Atrial Fibrillation (AF) Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Atrial Fibrillation (AF) Diagnostics Market Share by Players (2015-2020)
Table 25. Global Top Atrial Fibrillation (AF) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrial Fibrillation (AF) Diagnostics as of 2019)
Table 26. Global Atrial Fibrillation (AF) Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Atrial Fibrillation (AF) Diagnostics Product Solution and Service
Table 29. Date of Enter into Atrial Fibrillation (AF) Diagnostics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Atrial Fibrillation (AF) Diagnostics Market Size Share by Type (2015-2020)
Table 33. Global Atrial Fibrillation (AF) Diagnostics Revenue Market Share by Type (2021-2026)
Table 34. Global Atrial Fibrillation (AF) Diagnostics Market Size Share by Application (2015-2020)
Table 35. Global Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Atrial Fibrillation (AF) Diagnostics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 39. North America Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 41. North America Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 43. Europe Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 45. Europe Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 47. Europe Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 49. China Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 51. China Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 52. China Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 53. China Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 54. China Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 55. Japan Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 57. Japan Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 59. Japan Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 63. Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 65. Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 67. India Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 69. India Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 70. India Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 71. India Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 72. India Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Atrial Fibrillation (AF) Diagnostics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Atrial Fibrillation (AF) Diagnostics Market Share (2019-2020)
Table 75. Central & South America Atrial Fibrillation (AF) Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Atrial Fibrillation (AF) Diagnostics Market Share by Type (2015-2020)
Table 77. Central & South America Atrial Fibrillation (AF) Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Atrial Fibrillation (AF) Diagnostics Market Share by Application (2015-2020)
Table 79. Becton Company Details
Table 80. Becton Business Overview
Table 81. Becton Product
Table 82. Becton Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 83. Becton Recent Development
Table 84. Dickinson & Company Company Details
Table 85. Dickinson & Company Business Overview
Table 86. Dickinson & Company Product
Table 87. Dickinson & Company Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 88. Dickinson & Company Recent Development
Table 89. Medtronic Company Details
Table 90. Medtronic Business Overview
Table 91. Medtronic Product
Table 92. Medtronic Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 93. Medtronic Recent Development
Table 94. Boston Scientific Corp Company Details
Table 95. Boston Scientific Corp Business Overview
Table 96. Boston Scientific Corp Product
Table 97. Boston Scientific Corp Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 98. Boston Scientific Corp Recent Development
Table 99. Sanofi-Aventis Company Details
Table 100. Sanofi-Aventis Business Overview
Table 101. Sanofi-Aventis Product
Table 102. Sanofi-Aventis Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 103. Sanofi-Aventis Recent Development
Table 104. Zimmer Holdings Company Details
Table 105. Zimmer Holdings Business Overview
Table 106. Zimmer Holdings Product
Table 107. Zimmer Holdings Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 108. Zimmer Holdings Recent Development
Table 109. Abbott Company Details
Table 110. Abbott Business Overview
Table 111. Abbott Product
Table 112. Abbott Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 113. Abbott Recent Development
Table 114. Baxter International Business Overview
Table 115. Baxter International Product
Table 116. Baxter International Company Details
Table 117. Baxter International Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 118. Baxter International Recent Development
Table 119. AtriCure Company Details
Table 120. AtriCure Business Overview
Table 121. AtriCure Product
Table 122. AtriCure Revenue in Atrial Fibrillation (AF) Diagnostics Business (2015-2020) (Million US$)
Table 123. AtriCure Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Atrial Fibrillation (AF) Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Electrocardiogram (ECG) Features
Figure 3. Echocardiogram (echo) Features
Figure 4. Transesophageal Echocardiography (TEE) Features
Figure 5. Chest X-ray Features
Figure 6. Blood Tests Features
Figure 7. Stress Testing Features
Figure 8. Electrical Activity Testing Features
Figure 9. Global Atrial Fibrillation (AF) Diagnostics Market Share by Application: 2020 VS 2026
Figure 10. Cardio Centers Case Studies
Figure 11. Big Hospitals Case Studies
Figure 12. Heart Specialty Care Enterprises Case Studies
Figure 13. Atrial Fibrillation (AF) Diagnostics Report Years Considered
Figure 14. Global Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Atrial Fibrillation (AF) Diagnostics Market Share by Regions: 2020 VS 2026
Figure 16. Global Atrial Fibrillation (AF) Diagnostics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Atrial Fibrillation (AF) Diagnostics Market Share by Players in 2019
Figure 19. Global Top Atrial Fibrillation (AF) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrial Fibrillation (AF) Diagnostics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Atrial Fibrillation (AF) Diagnostics Revenue in 2019
Figure 21. North America Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Atrial Fibrillation (AF) Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
心房細動（AF）治療の世界市場（～2026年） Atrial fibrillation is an abnormal heart rhythm characterized by rapid and irregular beating of the atria. Often it starts as brief periods of abnormal beating which become longer and possibly constant over time. Often episodes have no symptoms. Occasionally there may be heart palpitations, fainting…- 心房細動（SPAF）治療における脳卒中予防の世界市場（～2026年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…
- 心房細動薬の世界市場（～2026年） Market Analysis and Insights: Global Atrial Fibrillation Drugs Market The global Atrial Fibrillation Drugs market size is projected to reach US$ 6158 million by 2026, from US$ 5987 million in 2020, at a CAGR of 2.7%% during 2021-2026. Global Atrial Fibrillation Drugs Scope and Market Size Atrial Fib…
- 左心耳（LAA）閉鎖装置の世界市場（～2026年） Left atrial appendage closure (LAAC) is a treatment strategy to reduce the risk of left atrial appendage blood clots from entering the bloodstream and causing a stroke in patients with non-valvular atrial fibrillation (AF). On March 13, 2015, the U.S. Food and Drug Administration approved the WATCHM…
- 菌血症検査の世界市場（～2026年） BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections. Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests …